Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Xylem Revises FY24 Revenue Guidance To $8.55B (Est $8.561B), Up Approximately 16%, With Organic Revenue Growth Of 5% - 6%, Up From 4% - 6%

Author: Benzinga Newsdesk | July 30, 2024 06:59am

 This represents an increase from the Company's previous full-year guidance of 15 to 16 percent on a reported basis and 4 to 6 percent on an organic basis.

Posted In: XYL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist